March 17, 2010 – New Results from PLATO trial suggest ticagrelor (Brilinta) leads to lower mortality and no increased risk of bleeding when compared to clopidogrel (Plavix) in patients with acute coronary syndrome who undergo coronary artery bypass graft (CABG) surgery. Patients are less likely to develop fatal outcomes when given ticagrelor...
The marketing agreement with Siemens Medical Solutions unvieled at ACC 2010 expands access to wireless PressureWire Aeris fractional flow reserve (FFR) measurement system. Siemen’s AXIOM Sensis XP cath lab hemodynamic recording system can now immediately display, measure and save FFR data. This documents the severity of coronary lesions, together...
Headlines
Search the Buyer's Guide
eNewsletters
Industry and technology news, conference updates and quick links to editorial features delivered to your desktop once weekly.
Late-breaking news from key medical conferences with an emphasis on technology introductions and announcements.
Be the first to know... sign up for eNews and receive breaking industry news, FDA announcements and more from our editors and partners.
Featured Video
Multimedia
None available presently.
Do you think transcatheter heart valves will revolutionize how structural heart disease is treated?
Print Edition
The Technology Solutions Resource for Diagnostic and Interventional Cardiology Professionals
Diagnostic & Invasive Cardiology is the widest-reaching provider of new product information, technology trends, application strategies and related connectivity solutions in the diagnostic and interventional cardiology markets.
